People prescribed the popular GLP-1 weight-loss drugs such as Ozempic and Mounjaro may experience benefits such as increased cognitive and behavioral health, according to scientists at WashU Medicine and the Veterans Affairs St. Louis Health Care System. But users of the injection medications may also face increased risks for pancreatitis and kidney conditions, among other illnesses. 

Read More